Healthcare -
Biotechnology - NASDAQ - US
$ 47.58
-3.14 %
$ 3.57 B
Market Cap
-12.69
P/E
Price Target
Average
--3.32%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
28.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Akero Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for AKRO of $46 , with forecasts ranging from
a
low of
$38 to a high of $56 .
AKRO Lowest Price Target
Wall Street Target
38 USD
-20.13%
AKRO Average Price Target
Wall Street Target
46 USD
-3.32%
AKRO Highest Price Target
Wall Street Target
56 USD
17.70%
REVENUE FORECAST
Revenue Forecast Chart AKRO
EBIT FORECAST
EBIT Forecast Chart AKRO
NET INCOME FORECAST
Net Income Chart AKRO